IP Library Granted Patent US 7,335,733
Granted Patent B2
US 7,335,733 · App. 10/226,489 · Granted Feb 26, 2008

Tissue cement proteins from

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,335,733
App. No.
10/226,489
Granted
Feb 26, 2008
Kind
B2
Abstract

The present invention relates to tissue cement proteins produced by certain species of blood-feeding ectoparasites. These proteins and compositions comprising these proteins are particularly useful for the temporary or permanent bonding of animal tissues to each other or to other biomaterials. The present invention also relates to the use of tissue cement proteins in the production of vaccines that protect animals against the bite of blood-sucking ectoparasites and the transmission of viruses, bacteria and other pathogens by such ectoparasites.

Claims (14)

1. An isolated and purified tissue cement protein consisting of the amino acid sequence of SEQ ID NO: 16.

2. An isolated and purified tissue cement protein of claim 1 consisting of amino acids 34-85 of SEQ ID NO: 16.

3. The isolated and purified tissue cement protein of claim 1 that binds to vertebrate tissues.

4. The tissue cement protein of claim 1 isolated from ticks.

5. The tissue cement protein of claim 4 isolated from Ixodid ticks.

6. The tissue cement protein of claim 5 isolated from Rhipicephalus appendiculatus.

7. The isolated and purified tissue cement protein of claim 1 , wherein said isolated and purified tissue cement protein further comprises one or more carbohydrate moieties.

8. The isolated and purified tissue cement protein of claim 7 , wherein said carbohydrate moieties are glycosaminoglycan moieties.

9. A recombinant tissue cement protein consisting of the sequence of SEQ ID NO:16.

10. A fusion protein comprising the tissue cement protein of claim 1 , wherein said tissue cement protein is genetically or chemically fused to one or more peptides or polypeptides.

11. A fusion protein comprising the tissue cement protein of claim 1 , wherein said tissue cement protein is cross-linked to one or more peptides or polypeptides.

12. A fusion protein comprising the tissue cement protein of claim 1 , wherein said tissue cement protein is attached to a label.

13. An immobilized tissue cement protein, wherein the tissue cement protein of claim 1 is bound to a support.

14. A vaccine comprising the isolated and purified tissue cement protein of claim 1 and a pharmaceutically acceptable excipient, wherein said vaccine inhibits tick feeding.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 038995/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2007
From: EVOLUTEC LIMITED
To: MERIAL LIMITED
Reel/Frame 019575/0773 →
CORRECTIVE ASSIGNMENT TO CORRECT ASSIGNOR NAME/ADDRESS, PREVIOUSLY RECORDED ON REEL:017138 FRAME:0330 Recorded Feb 23, 2006
From: EVOLUTEC LIMITED
To: EVOLUTEC LIMITED
Reel/Frame 017304/0924 →
ASSIGNEE CHANGE OF ADDRESS Recorded Aug 2, 2005
From: NUTTALL, PATRICIA ANNE; PAESEN, GUIDO CHRISTIAAN
To: EVOLUTEC LIMITED
Reel/Frame 017138/0277 →
ASSIGNEE CHANGE OF ADDRESS Recorded Aug 2, 2005
From: NUTTALL, PATRICIA ANNE; PAESEN, GUIDO CHRISTIAAN
To: EVOLUTEC LIMITED
Reel/Frame 017138/0330 →